| Entry |
|
| Name |
Desfesoterodine (INN) |
| Formula |
C22H31NO2
|
| Exact mass |
341.2355
|
| Mol weight |
341.487
|
| Structure |

|
| Simcomp |
|
| Remark |
|
| Efficacy |
Overactive bladder agent, Muscarinic acetylcholine receptor antagonist |
| Target |
CHRM3 [HSA:1131] [KO:K04131] |
| Pathway |
| hsa04020 | Calcium signaling pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
| hsa04725 | Cholinergic synapse |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
G GENITO URINARY SYSTEM AND SEX HORMONES
G04 UROLOGICALS
G04B UROLOGICALS
G04BD Urinary antispasmodics
G04BD13 Desfesoterodine
D10853 Desfesoterodine (INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM3
D10853 Desfesoterodine (INN)
|
| Other DBs |
|
| KCF data |
ATOM 25
1 C1c C 13.7694 -15.0974
2 N1c N 14.9576 -15.7963
3 C1b C 16.1458 -15.1673
4 C1b C 17.3340 -15.8662
5 C1c C 18.6620 -15.1673
6 C8y C 19.8503 -15.8662
7 C8x C 21.0385 -15.1673
8 C8y C 22.2966 -15.8662
9 C1b C 23.4848 -15.2372
10 C1a C 13.7694 -13.6995
11 C1c C 14.9576 -17.2641
12 C1a C 13.6995 -17.8932
13 C1a C 16.2157 -17.8932
14 C8y C 19.8503 -17.2641
15 C8x C 22.2966 -17.2641
16 C8x C 21.0385 -17.9631
17 O1a O 18.6620 -17.8932
18 O1a O 24.6730 -15.9361
19 C1a C 12.5812 -15.7963
20 C8y C 18.6620 -13.6995
21 C8x C 19.9202 -13.0005
22 C8x C 19.9202 -11.6026
23 C8x C 18.7319 -10.9037
24 C8x C 17.4738 -11.5327
25 C8x C 17.4738 -12.9306
BOND 26
1 1 2 1
2 2 3 1
3 3 4 1
4 5 4 1
5 5 6 1
6 6 7 1
7 7 8 2
8 8 9 1
9 1 10 1
10 2 11 1
11 11 12 1
12 11 13 1
13 6 14 2
14 8 15 1
15 14 16 1
16 16 15 2
17 14 17 1
18 9 18 1
19 1 19 1
20 5 20 1 #Down
21 20 21 2
22 21 22 1
23 22 23 2
24 23 24 1
25 24 25 2
26 20 25 1
|